North America Molecular Diagnostics Market
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services.
North America Molecular Diagnostics Market Overview
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.
High prevalence of Infectious diseases in USA is growing the demand for molecular diagnostic market. According to the Centers of Diseases Control and Prevention, Hepatics C is the leading cause of death in America. In 2014, deaths associated with Hepatics C were all-time high of 19,659. Currently, around 3.5 million Americans are still living with Hepatic C. Additionally; Tuberculosis is also becoming one of the leading causes of death. According to World Health Organisation (WHO), “tuberculosis, malaria and AIDS have caused over 300 million illnesses and more than 5 million deaths each year worldwide and the most effected region is North America. Hence, it could be expected that high prevelance of diseases could result in growth of molecular devices market in North America.
North America Molecular Diagnostics Market Segmentation
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into US, Canada and Mexico.
North America Molecular Diagnostics Market Key Companies
The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report includeAbbott Laboratories,Qiagen N.V,Roche Diagnostics,Grifols,Siemens Healthcare (Siemens AG),Becton Dickinson and Company and Danaher Corporation.
North America Molecular Diagnostics Market Segmentation
Market Segmentation:
By Product & Services
- Reagents & Kits
- Instruments
- Software& Services
By Technology
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- Hybridization
- DNA Sequencing & Next-Generation Sequencing
- Microarray
- Other Technologies
By Application
- Infectious Diseases
- Chlamydia Trachomatis & Neisseria Gonorrhoea
- Hepatitis B & Hepatitis C
- Human Papillomavirus
- Human Immunodeficiency Virus
- Tuberculosis
- Methicillin-Resistant Staphylococcus Aurous
- Others
- Oncology
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Other Cancers
- Blood Screening
- Genetic Tests
- Microbiology
- Other Applications
By End User
- Hospital & Academic Laboratories
- Reference Laboratories
- Other End Users
By Country
- US
- Canada
- Mexico
- Rest of North America
Company Profiled
- Abbott Laboratories
- Qiagen N.V
- Roche Diagnostics
- Grifols
- Siemens Healthcare (Siemens AG)
- Becton Dickinson and Company
- Danaher Corporation
Unique Offerings from KBV Research
- Exhaustive coverage of North America Molecular Diagnostics Market
- Highest number of market tables
- Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
- Subscription based model available
- Free of cost quarterly updates
- Free of cost automatic pdf report generation
- Guaranteed best price
- Assured post sales research support with 10% customization free
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Molecular Diagnostics Market, by Product & Services
1.4.2 North America Molecular Diagnostics Market, by Technology
1.4.3 North America Molecular Diagnostics Market, by Application
1.4.4 North America Molecular Diagnostics Market, by End User
1.4.5 North America Molecular Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Executive Summary
Chapter 3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. North America Molecular Diagnostics Market
4.1 North America Molecular Diagnostics Market by Product & Services
4.1.1 North America Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 North America Molecular Diagnostics Instruments Market by Country
4.1.3 North America Molecular Diagnostics Software & Services Market by Country
Chapter 5. North America Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 North America Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 North America Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 North America Hybridization Molecular Diagnostics Market by Country
5.1.4 North America DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 North America Microarray Molecular Diagnostics Market by Country
5.1.6 North America Other Technologies Market by Country
Chapter 6. North America Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 North America Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 North America Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 North America Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 North America Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 North America Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 North America Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 North America Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 North America Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 North America Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 North America Oncology Molecular Diagnostics Market by Country
6.1.4 North America Oncology Molecular Diagnostics Market by Type
6.1.4.1 North America Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 North America Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 North America Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 North America Other Cancers Molecular Diagnostics Market by Country
6.1.5 North America Blood Screening Molecular Diagnostics Market by Country
6.1.6 North America Genetic Tests Molecular Diagnostics Market by Country
6.1.7 North America Microbiology Molecular Diagnostics Market by Country
6.1.8 North America Other Applications Market by Country
Chapter 7. North America Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 North America Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 North America Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 North America Molecular Diagnostics Market for Other End Users by Country
Chapter 8. North America Molecular Diagnostics Market by Country
8.1 Introduction
8.2 US Molecular Diagnostics Market
8.2.1 US Molecular Diagnostics Market by Product & Services
8.2.2 US Molecular Diagnostics Market by Technology
8.2.3 US Molecular Diagnostics Market by Application
8.2.3.1 US Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 US Oncology Molecular Diagnostics Market by Type
8.2.4 US Molecular Diagnostics Market by End User
8.3 Canada Molecular Diagnostics Market
8.3.1 Canada Molecular Diagnostics Market by Product & Services
8.3.2 Canada Molecular Diagnostics Market by Technology
8.3.3 Canada Molecular Diagnostics Market by Application
8.3.3.1 Canada Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Canada Oncology Molecular Diagnostics Market by Type
8.3.4 Canada Molecular Diagnostics Market by End User
8.4 Mexico Molecular Diagnostics Market
8.4.1 Mexico Molecular Diagnostics Market by Product & Services
8.4.2 Mexico Molecular Diagnostics Market by Technology
8.4.3 Mexico Molecular Diagnostics Market by Application
8.4.3.1 Mexico Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 Mexico Oncology Molecular Diagnostics Market by Type
8.4.4 Mexico Molecular Diagnostics Market by End User
8.5 Rest of North America Molecular Diagnostics Market
8.5.1 Rest of North America Molecular Diagnostics Market by Product & Services
8.5.2 Rest of North America Molecular Diagnostics Market by Technology
8.5.3 Rest of North America Molecular Diagnostics Market by Application
8.5.3.1 Rest of North America Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Rest of North America Oncology Molecular Diagnostics Market by Type
8.5.4 Rest of North America Molecular Diagnostics Market by End User
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
LIST OF TABLES
TABLE 1 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 2 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 3 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 4 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 5 NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 6 NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 7 NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 8 NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 9 NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 10 NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 11 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 12 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 13 NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 14 NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 15 NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 16 NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 17 NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 18 NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 19 NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 20 NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 21 NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 22 NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 23 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 24 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 25 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 26 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 27 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 28 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 29 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 30 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 31 NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 32 NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 33 NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 34 NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 35 NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 36 NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 37 NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 38 NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 39 NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 40 NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 41 NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 42 NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 43 NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 44 NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 45 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 46 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 47 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 48 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 49 NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 50 NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 51 NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 52 NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 53 NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 54 NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 55 NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 56 NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 57 NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 58 NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 59 NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 60 NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 61 NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 62 NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 63 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 64 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 65 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 66 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 67 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 68 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 69 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 70 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 71 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 72 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 73 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 74 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 75 US MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 76 US MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 77 US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 78 US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 79 US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 80 US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 81 US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 82 US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 83 US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 84 US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 85 US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 86 US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 87 US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 88 US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 89 CANADA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 90 CANADA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 91 CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 92 CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 93 CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 94 CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 95 CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 96 CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 97 CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 98 CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 99 CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 100 CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 101 CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 102 CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 103 MEXICO MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 104 MEXICO MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 105 MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 106 MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 107 MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 108 MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 109 MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 110 MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 111 MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 112 MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 113 MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 114 MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 115 MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 116 MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 117 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 118 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 119 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 120 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 121 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 122 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 123 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 124 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 125 REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 126 REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 127 REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 128 REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 129 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 130 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 131 KEY INFORMATION – ABBOTT LABORATORIES.
TABLE 132 KEY INFORMATION – QUIAGEN N.V.
TABLE 133 KEY INFORMATION – ROCHE DIAGNOSTIC
TABLE 134 KEY INFORMATION – GRIFOLS
TABLE 135 KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)
TABLE 136 KEY INFORMATION – BECTON DICKINSON AND COMPANY
TABLE 137 KEY INFORMATION – DANAHER CORPORATION
